Adma Biologics ADMA
NASDAQ ADMA
$12.79 +0.06 (+0.47%)
At close: Nov 9, 2026 · 4:00 PM EST

Adma Biologics (ADMA) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Adma Biologics (ADMA) posted Weighted Average Shares Outstanding (Diluted) of 225.82 million for Q3 2026, down 7.7% from 244.66 million a year earlier and down 2.0% from the prior quarter.

Analysis

Adma Biologics (ADMA) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Adma Biologics' Weighted Average Shares Outstanding (Diluted) came in at 244.9 million, up 0.6% from FY2024.

  • Annual Weighted Average Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
  • In prior years, Adma Biologics' Weighted Average Shares Outstanding (Diluted) was 243.34 million in FY2024 (+8.6%), 223.98 million in FY2023 (+13.2%), 197.87 million in FY2022 (+41.8%) and 139.58 million in FY2021 (+62.0%).
  • The Q3 2026 figure stands as the lowest quarterly Weighted Average Shares Outstanding (Diluted) since Q4 2023.
  • On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has declined in each of the last three quarters, with an average decline of 0.2% over the last eight quarters.
  • The strongest year-over-year quarter for Weighted Average Shares Outstanding (Diluted) in the past five years was Q1 2022, with growth of 69.3%; the weakest was Q3 2026, with a decline of 7.7%.
  • According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 230.34 million (Q2 2026), 239.96 million (Q1 2026) and 244.9 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 2.45 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 1.77 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - 1.96 Bn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 1.25 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 5.75 Bn
10 Adma Biologics 2.87 Bn 2.39 Bn 99.92 Mn 225.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 225.82 Mn
Jun 30, 2026 230.34 Mn
Mar 31, 2026 239.96 Mn
Dec 31, 2025 244.90 Mn
Sep 30, 2025 244.66 Mn
Jun 30, 2025 248.61 Mn
Mar 31, 2025 244.68 Mn
Dec 31, 2024 243.34 Mn
Sep 30, 2024 244.80 Mn
Jun 30, 2024 242.17 Mn
Mar 31, 2024 236.41 Mn
Dec 31, 2023 223.98 Mn
Sep 30, 2023 233.76 Mn
Jun 30, 2023 222.68 Mn
Mar 31, 2023 221.92 Mn
Dec 31, 2022 197.87 Mn
Sep 30, 2022 196.38 Mn
Jun 30, 2022 196.35 Mn
Mar 31, 2022 195.87 Mn
Dec 31, 2021 139.58 Mn
API Access

Adma Biologics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ADMA&period=max&api_key=YOUR_API_KEY